_edited.png)
RISK CONCERN
Investment Strategy, Risk Analysis, and Insights by Chartered Professionals
Teladoc Health, Inc. (XNYS:TDOC) In-Depth Stock/Fundamental/Options Analysis Today
Primary Facts
TDOC
Name:
Teladoc Health, Inc. (XNYS:TDOC)
Sector:
- 62578.00K
Industry:
Health Information Services
CEO:
Mr. Jason Gorevic
Total Employees:
5,100
Our Technological Advancement Rating
Our Rating:
D
Technological advancement compared to industry is -99.87% lower
ANALYSIS OF ALL CRITICAL FACTORS & RISKS RELATED TO THE STOCK & FUNDAMENTAL/LONG-TERM ANALYSIS OF TELADOC HEALTH, INC.(TDOC) AS PER DATA ANALYSIS OF LAST 3 YEARS AND COMPARISON WITH COMPETITORS/PEERS, AND HEALTH INFORMATION SERVICES INDUSTRY. DATE: 07/09/2022
Primary Targets/Price Insights
Previous Close ($) :
30.18
One Month Price Target:
$30.33
Six Month Price Target :
$31.05
Likely Price in One Year's Time:
Ticker:
$31.93
Likely Trading Range Today Under (Normal Volatility)
$29.94
Price Upper limit ($) :
$30.4
Price Lower limit ($) :
Crash Risk Prep/Key Price Levels (High Volatility/Risk)
Price, as per data analysis, isn't likely to fall below:
Today:
$27.37
This week:
$23.91
This month :
$17.63
Other Primary facts
Market Cap:
4.69B
Market Cap Classification:
Mid Cap
Number of Shares
IPO Date:
161.66M
Best/Worst Daily Performance (Last 3+ Years)
Highest Daily Appreciation:
18.13%
-40.15%
Worst Daily Decline:
Our Options Trading Entry Points
Iron Condor entry points for options expiring in 1 week's time
Low risk (<2%) entry points
Buy Call:
Sell Call:
Buy Put:
Sell Put:
$43.21
$37.31
$17.15
$23.05
Medium risk (<10%) entry points
Buy Call
Sell Call
$35.39
Buy Put:
Sell Put:
$34.13
$24.96
$26.23
These entry points can be used for other strategies, such as butterflies, straddles, etc.
Risk-Adjusted returns (Sharpe Ratio) of
TDOC
Sharpe Ratio:
-0.88%
Comparison:
TDOC, is amongst the top 40% stocks with lowest risk-adjusted returns
Sharpe ratio is -185.71% lower than the industry
& is -138.62% lower than the market/S&P 500 average
Average Returns/Yield of
TDOC
Daily returns:
-0.03%
Weekly returns:
-0.15%
Monthly returns:
-0.62%
Yearly returns:
5.07%
Comparison of returns:
Average annual returns/yield (last 3 years) is -246.03% below industry average
Classification:
TDOC, is amongst the top 40% lowest yielding stocks in terms of daily returns
Results of T-Test of Returns:
0.87
Statistical test of Returns:
TDOC has yielded returns statistically similar to the market
Volatility (measured by Standard Deviation)
Daily Volatility:
4.51%
Weekly Volatility:
10.09%
Monthly Volatility:
20.18%
Yearly Volatility:
69.90%
Volitlilty of last five days (Measured by Standard Deviation)
Average Volatility of this Week:
0.92%
Volatility in last five trading days has been -79.52% below long-term volatility
Value at Risk Analysis (VaR)
Daily VaR:
-9.30%
Weekly VaR:
-20.79%
Monthly VaR:
-41.58%
How Much Can the price of
TDOC
Decline in a Recession?
Likely price decline in a recession:
Base case (decline):
-37%
Worst case (decline):
>85%
This translates to price declining to:
$18.97
This translates to price declining to:
$4.53
Severe Crash Probability
Risk of crash in next 6/12 months: Low (<25%)
What is Value at Risk (VaR)?
Risk Fundamentals
TDOC is a 193.45% riskier investment compared to the market/S&P 500 & is 151.40% riskier than Nasdaq (IXIC)
Risk (measured by volatility) is 32.65% above industry average
Overall, it is amongst the top 50% most risky stocks
Beta Examination of
TDOC
Beta in relation to market/S&P 500--0.86
Expected beta in 1 year's time:
1.22
Expected beta in 3 year's time:
1.725
Unlevered (debt free) Beta:
0.736
Beta in relation to Nasdaq (XNAS):
1.032
Beta in relation to all global stocks::
0.264
Beta Comparison & Analysis
Beta of competitors/peers::
0.893
Beta is -3.51% lower than peers
Average Industry Beta:
0.87
Beta is -0.92% below industry average
Sustainable Growth Rate Analysis
Sustainable growth rate for this stock/firm:
-
-
Alpha provided | Alpha Analysis
Alpha provided:
-0.165
Alpha is 307.98% above industry average alpha yield
Alpha is -1048% below the market average
Analysis of Cost of Capital of
TDOC
Equity cost of capital:
0.091
Equity cost of capital is -0.60% below industry mean WACC
Unlevered (without debt) cost of capital:
7.73%
Before-tax cost of debt:
4.02%
After-tax cost of debt:
3.17%
Overall debt rating:
Lower BB medium grade (Fifth highest grade)
Weighted average cost of capital (WACC):
3.17%
WACC is 2.12% above industry mean WACC
Key Per-Share Metrics & Analysis
Revenue per share:
$13.26
Revenue growth rate per share of (3Y):
0.53
Annual revenue growth rate is -27.27% below industry average
EPS:
-$43.03
Expected Annual growth rate of EPS (3Y):
25.53%
Expected future EPS growth rate is -46.24% lower than the Health Information Services industry
Free cash flow (FCF) per share:
$0.59
-
-
Debt per share
$9.73
EBITDA per share
-$41.15
Valuation Analysis Today of
TDOC
P/E Ratio:
0
P/E Ratio of Competitors/Peers:
23.1
P/E ratio is -100.00% lower than main peers & is higher than the industry
-
TDOC is -100.19% undervalued if valued using industry average P/E ratio
-
-
P/S (Price to Sales ratio):
2.28
Price to sales ratio is -69.99% below the industry mean
P/B (Price to book value ratio):
0.53
Price to free cash flow: 51.45
Price to free cash flow ratio is 19.90% higher than the industry
Net income growth rate (3Y):
221.31%
Net income growth rate is -87.37% lower than the industry average net income growth rate
Dividend Analysis
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dividend History:
--$0.00
--$0.00
--$0.00
--$0.00
--$0.00
--$0.00
-
In-depth Debt & Leverage Analysis
Debt to equity ratio:
17.20%
Net debt to equity ratio:
8.20%
Debt to assets ratio:
14.18%
Net debt to assets ratio:
6.76%
Debt-to-asset ratio is -58.49% below industry average
Ability to repay debt:
Interest coverage ratio:
-104.4
Interest coverage ratio is -793.08% less than industry average
Looking forward:
Debt growth rate:
-10.70%
Annual debt growth is -126% lower than industry average debt growth rate
Debt repayment rate in last quarter: 0.00%
Analysis of Key Statistics
Correlation of price movement with the market:
0.248
Statistical significance of correlation:
TDOC has a statistically significant correlation with the market
Average Correlation of the industry with the market:
0.376
Stock price is -34.16% less correlated with the market compared to the industry average correlation
R Squared (percentage of price movement explained by movement of the market):
0.376
Correlation of price movement with Nasdaq (^IXIC):
-0.096
Covariance of price movement with the market:
-0.25
Kurtosis
10.163
Returns have a significant fat-tails (leptokurtic), i.e., returns considerably higher or lower than the mean returns are more probable, compared to assets with normally distributed returns
Skewness of returns:
-0.935
Returns are left (negative) skewed; mean returns are lower than median and mode returns
Fundamental Analysis & Dupont Analysis of
TDOC
Gross Profit Margin Ratio:
271%
Operating Profit Margin Ratio:
-319.45%
Operating profit margin is 1688.71% higher than the industry
Net Profit Margin Ratio:
271%
Effective Tax Rate:
0.61%
Effective tax rate is -96.91% lower than the industry
Dupont Method
Net Profit Margin
Return on Equity Ratio (ROE):
×
ROA
=
×
-75.51%
Return on equity (ROE) is 2216.21% higher than the industry
Financial Leverage
Asset Turnover Ratio (ROA):
-62.24%
Return on assets (ROA) is 3485.12% higher than the industry
Financial Leverage:
1.2x
Current Ratio:
3.94
Current ratio is -30.06% below industry average
Cash Conversion Cycle (days):
13.9
Cash conversion cycle is -71.67% below industry average
The remaining useful life of property plant & equipment is: 2.9 years
Stock based compensation to net income ratio:
-0.88%
In-depth Efficiency Analysis
Revenue generated per employee:
420.5K
Each employee generates 1% more revenue than industry average revenue per employee
EBITDA generated per employee:
- 1304.4K
Each employee generates 3082% more EBITDA than industry average revenue per employee
Profit generated per employee:
- 1353.7K
Each employee generates 1608% more net income/profit than industry average revenue per employee
Free cash flow (FCF) generated per employee:
- 12.3K
Each employee generates -197% less free cash flow than industry average revenue per employee
Assets/Capital per employee
1.9M
Each employee generates -197% less free cash flow than industry average revenue per employee
Research & Development (R&D) Analysis
Research & development (R&D) investment growth rate-- 89.09%
Growth rate in R&D investment/expenditure is -780.45% lower than the industry
Competitors/Peer firms of
TDOC
ELANCO ANIMAL HEALTH INCORPORATED (XNYS:ELAN)
TELEFLEX INCORPORATED (XNYS:TFX)
Qiagen NV (XNYS:QGEN)
CARDINAL HEALTH, INC. (XNYS:CAH)
SMITH & NEPHEW PLC (XNYS:SNN)
UNIVERSAL HEALTH SERVICES, INC. (XNYS:UHS)
DR.REDDY'S LABORATORIES LTD (XNYS:RDY)
HOA BINH RUBBER JOINT STOCK COMPANY (XSTC:HRC)
GINKGO BIOWORKS HOLDINGS, INC. (XNYS:DNA)
Current Analyst Ratings
Strong buy�17%
Buy�25%
Hold�13%
Sell�0%
Strong sell�0%
Overall analyst sentiment is: Buy
Income Statement
Period:
TTM
Date:
3/31/22
Revenue:
2.14B
Cost of Revenue:
Gross Profit:
R&D Expense
General & Admin Expenses:
Selling, General & Admin Expenses
Sales and Marketing Expenses
Other Expenses :
Operating Expenses :
Cost & Expenses :
Interest Income:
Interest Expenses:
Depreciation & Amortization:
EBITDA:
Operating Income:
Other Income Expenses:
Income Before Tax:
Income Tax Expense:
Net Income:
Balance Sheet
Date:
Calendar Year:
Period:
Cash & Cash Equivalents:
Short Term Investments:
Cash & Short Term Investments:
Net Receivables:
Inventory:
Other Current Assets:
Total Current Assets:
PP&E:
Goodwill:
Intangible Assets:
Long Term Investments:
Tax Assets:
Other Non-Current Assets:
Total Non-Current Assets:
Other Assets:
Total Assets:
Accounts Payable:
Short Term Debt:
Tax Payables:
Deferred Revenue:
Other Current Liabilities:
Total Current Liabilities:
Long Term Debt:
Other Non-Current Liabilities:
Total Non Current Liabilities:
Other Liabilities:
Total Liabilities:
Common Stock:
Retained Earnings:
Accumulated Other Comprehensive Loss:
Other Total Stockholders' Equity:
Total Stockholders' Equity:
Total Liabilities and Stockholders' Equity:
Total Investments:
Total Debt:
Net Debt:
691.32M
1.45B
321.29M
437.76M
1.14B
705.00M
214.51M
1.68B
-
63.72M
230.07M
- 6652395.00K
- 6850332.00K
- 6903667.00K
- 6946181.00K
- 42514.00K
- 6903667.00K
Statement of Cash Flow
Date:
Period:
62.88M
Differed Income Tax :
- 2319.00K
Stock Based Compensation :
60.44M
Change in Working Capital :
- 83634.00K
Accounts Receivables:
- 27842.00K
Other Working Capital:
- 41340.00K
Other Non-Cash Items:
6.61B
Net Cash Provided by Operating Activities:
- 31747.00K
Investments in PP&E:
-
Net Acquisitions:
-
Purchases of Investments:
-
Sales/Maturities of Investments:
Other Investing Activities:
Net Cash Used for Investing Activities:
Debt Repayment:
Common Stock Issued:
Common Stock Repurchased:
Dividend Paid:
Other Financing Activities:
Net Cash Used Provided by Financing Activities:
Effect of FOREX on Changes in Cash:
Net Changes in Cash:
Cash at End of Period:
Cash at Beginning of Period:
Operating Cash Flow:
Capital Expenditure:
Free Cash Flow (FCF):
3/31/22
2022
Q1
836.44M
2.54M
838.99M
214.35M
70.65M
84.06M
1.21B
73.97M
7.90B
1.88B
-
-
26.63M
9.88B
-
11.09B
47.41M
13.05M
16.56M
83.85M
162.38M
306.69M
1.57B
9.70M
1.64B
-
1.95B
161.00K
- 8023279.00K
- 11424.0K
-
March 31, 2022 at 6:00:00 AM
2.37B
9.14B
11.09B
-
1.59B
749.6M
-
- 27567.00K
- 27567.00K
-
-
-
-
2.82M
2.82M
- 538.00K
- 57036.00K
836.44M
893.48M
- 31747.00K
- 30831.00K
- 62578.00K
Our Proprietary Portfolio Rating
Our Rating:
B
Price Forecast/Expected Price in Next 5 Years of
TDOC
2023
2024
2025
2026
2027
$32.09
$33.95
$35.92
$38.00
$40.20